Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Increased level of acute phase reactants in patients infected with modern Mycobacterium tuberculosis genotypes in Mwanza, Tanzania

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The association between conventional risk factors and diabetes is weak among urban Tanzanians

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Daniel Faurholt-Jepsen
  • Nyagosya Range
  • George PrayGod
  • Kidola Jeremiah
  • Maria Faurholt-Jepsen
  • Martine G Aabye
  • John Changalucha
  • Dirk Lund Christensen
  • Harleen M S Grewal
  • Torben Martinussen
  • Henrik Krarup
  • Daniel R Witte
  • Aase B Andersen
  • Henrik Friis
View graph of relations

OBJECTIVE: Strong evidence suggests diabetes may be associated with tuberculosis (TB) and could influence TB treatment outcomes. We assessed the role of diabetes on sputum culture conversion and mortality among patients undergoing TB treatment.

METHODS: A total of 1250 Tanzanian TB patients were followed prospectively during TB treatment with sputum culture after 2 and 5 months. Survival status was assessed at least 1 year after initiation of treatment. At baseline, all participants underwent testing for diabetes and HIV, and the serum concentration of the acute phase reactant alpha-1 glycoprotein (AGP) was determined.

RESULTS: There were no differences between participants with and without diabetes regarding the proportion of positive cultures at 2 (3.8% vs. 5.8%) and 5 (1.3% vs. 0.9%) months (P > 0.46). However, among patients with a positive TB culture, relatively more patients with diabetes died before the 5-month follow-up. Within the initial 100 days of TB treatment, diabetes was associated with a fivefold increased risk of mortality (RR 5.09, 95% CI 2.36; 11.02, P < 0.001) among HIV uninfected, and a twofold increase among HIV co-infected patient (RR 2.33 95% CI 1.20; 4.53, P = 0.012), while diabetes was not associated with long-term mortality. Further adjustment with AGP did not change the estimates.

CONCLUSION: Diabetes considerably increases risk of early mortality during TB treatment. The effect may not be explained by increased severity of TB, but could be due to impaired TB treatment response. Research is needed to clarify the mechanism and to assess whether glycaemic control improves survival.

Original languageEnglish
JournalTropical medicine & international health : TM & IH
Volume18
Issue number7
Pages (from-to)822-9
Number of pages8
ISSN1360-2276
DOIs
Publication statusPublished - Jul 2013

    Research areas

  • Blood Glucose, Diabetes Complications, Female, HIV Infections, Humans, Male, Middle Aged, Orosomucoid, Prospective Studies, Risk Factors, Tanzania, Treatment Outcome, Tuberculosis, Pulmonary, Young Adult, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

ID: 51558844